Reduced probability of improving viro‐immunological state in subjects with vertical transmission of HIV reaching adult age: A multicenter retrospective cohort study. Issue 2 (9th February 2023)
- Record Type:
- Journal Article
- Title:
- Reduced probability of improving viro‐immunological state in subjects with vertical transmission of HIV reaching adult age: A multicenter retrospective cohort study. Issue 2 (9th February 2023)
- Main Title:
- Reduced probability of improving viro‐immunological state in subjects with vertical transmission of HIV reaching adult age: A multicenter retrospective cohort study
- Authors:
- Pennati, Francesca
Calza, Stefano
Di Biagio, Antonio
Mussini, Cristina
Rusconi, Stefano
Bonora, Stefano
Borghetti, Alberto
Quiros‐Roldan, Eugenia
Sarteschi, Giovanni
Menozzi, Marianna
Ferrara, Micol
Celotti, Anna
Ciccullo, Arturo
Giacomet, Vania
Izzo, Ilaria
Dotta, Laura
Badolato, Raffaele
Castelli, Francesco
Focà, Emanuele - Abstract:
- Abstract: Introduction: Young adults with vertical transmission (VT) of human immunodeficiency virus (HIV) represent a fragile population. This study evaluates factors associated with viro‐immunological outcome of these patients. Methods: We performed a multicenter study including HIV‐infected subjects with VT ≥ 18 years old from six Italian clinics. Subjects were observed from birth to death, lost to follow‐up, or last visit until December 31, 2019. Condition of "optimal viro‐immunological status" (OS) was defined as the simultaneous presence of HIV ribonucleic acid (RNA) < 50 copies/mL, CD4+ > 500 cells/mm 3, and CD4+/CD8+ ratio ≥ 1. Results: A total of 126 subjects were enrolled. At 18 years of age, 52/126 (44.4%) had HIV‐RNA > 50 copies/mL, 47/126 (38.2%) had CD4+ < 500/mm 3, and 78/126 (67.2%) had CD4+/CD8+ < 1; 28 subjects (23.7%) presented in the condition of OS. Having a CD4+/CD8+ ratio ≥ 1 at 18 years of age was related with an increased probability of shift from suboptimal viro‐immunological status (SOS) to OS (HR: 7.7, 95% confidence interval [CI]: 4.23–14.04), and a reduced risk of shift from the OS to the SOS (HR: 0.49, 95% CI: 0.26–0.92). Acquired immunodeficiency syndrome (AIDS) diagnosis significantly reduced the probability of shift from a viro‐immunological SOS to OS (HR: 0.09, 95% CI: 0.03–0.30). Subjects who had not achieved an OS at 18 years of age had an increased risk of discontinuation of combination antiretroviral therapy (cART, p = .019).Abstract: Introduction: Young adults with vertical transmission (VT) of human immunodeficiency virus (HIV) represent a fragile population. This study evaluates factors associated with viro‐immunological outcome of these patients. Methods: We performed a multicenter study including HIV‐infected subjects with VT ≥ 18 years old from six Italian clinics. Subjects were observed from birth to death, lost to follow‐up, or last visit until December 31, 2019. Condition of "optimal viro‐immunological status" (OS) was defined as the simultaneous presence of HIV ribonucleic acid (RNA) < 50 copies/mL, CD4+ > 500 cells/mm 3, and CD4+/CD8+ ratio ≥ 1. Results: A total of 126 subjects were enrolled. At 18 years of age, 52/126 (44.4%) had HIV‐RNA > 50 copies/mL, 47/126 (38.2%) had CD4+ < 500/mm 3, and 78/126 (67.2%) had CD4+/CD8+ < 1; 28 subjects (23.7%) presented in the condition of OS. Having a CD4+/CD8+ ratio ≥ 1 at 18 years of age was related with an increased probability of shift from suboptimal viro‐immunological status (SOS) to OS (HR: 7.7, 95% confidence interval [CI]: 4.23–14.04), and a reduced risk of shift from the OS to the SOS (HR: 0.49, 95% CI: 0.26–0.92). Acquired immunodeficiency syndrome (AIDS) diagnosis significantly reduced the probability of shift from a viro‐immunological SOS to OS (HR: 0.09, 95% CI: 0.03–0.30). Subjects who had not achieved an OS at 18 years of age had an increased risk of discontinuation of combination antiretroviral therapy (cART, p = .019). Conclusions: Only a small proportion of subjects with VT of HIV reached the adult age with "OS". Transition to the adult care with a compromised viro‐immunological condition represents a negative driver for future optimal infection control, with a higher risk of discontinuation of cART and a reduced probability to improve the immunological status later in the years. Abstract : … (more)
- Is Part Of:
- Immunity, inflammation and disease. Volume 11:Issue 2(2023)
- Journal:
- Immunity, inflammation and disease
- Issue:
- Volume 11:Issue 2(2023)
- Issue Display:
- Volume 11, Issue 2 (2023)
- Year:
- 2023
- Volume:
- 11
- Issue:
- 2
- Issue Sort Value:
- 2023-0011-0002-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2023-02-09
- Subjects:
- antiretroviral therapy -- discontinuation -- HIV -- vertical transmission -- viro‐immunological effectiveness
Immunology -- Periodicals
Immunity -- Periodicals
Inflammation -- Periodicals
616.079 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2050-4527 ↗
http://onlinelibrary.wiley.com/ ↗
http://www.wileyopenaccess.com/view/journals.html ↗ - DOI:
- 10.1002/iid3.778 ↗
- Languages:
- English
- ISSNs:
- 2050-4527
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26057.xml